abstract |
The invention relates to compounds of formula (I), n n n Wherein X, Y, R 1, R 2, R 3, R 4 and R 5 as described in the specification based; on its pharmaceutically acceptable salts and such compounds as medicaments, in particular as modulators of the CXCR3 receptor use. |